ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Inovelon, Suspension zum Einnehmen - 460 ml
62066001 Eisai Pharma AG
Inovelon, Suspension zum Einnehmen13.06.2012
  13.06.2012
Rufinamide (N03AF03) 
WHO-DDD 
01.07.10.460 ml
01.07.10. 
B  
Yes 
IPCI
68.01Yes
    
10 %90.40
7680620660018Synthetika
5320666 
Composition
rufinamidum 40 mg, sorbitolum liquidum non cristallisabile corresp. sorbitolum 175 mg, propylenglycolum 25 mg, cellulosum microcristallinum, carmellosum natricum, acidum citricum, hydroxyethylcellulosum, dimeticonum, polysorbatum 65, methylcellulosum, silica colloidalis hydrica, macrogoli stearas, E 210 max. 0.005 mg, E 200, acidum sulfuricum, poloxamerum 188, aromatica (Orange) cum alcohol benzylicus, E 202, E 218 1.2 mg, propylis parahydroxybenzoas 0.3 mg, aqua purificata, ad suspensionem pro 1 ml corresp. natrium max. 0.22 mg.
Packungsbestandteile
Suspension (oral) 
  
 
Active AgentDose
Rufinamidum40 mg/ml
BAG: Active AgentDose
Rufinamidum40 mg
 
Inactive agents additional_information
Alcohol Benzylicus  
Aromatica  
E 202 conserv.
E 218 conserv.
Propylis Parahydroxybenzoas  
 
Source
Data was imported : 06.10.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home